UP!
|
Type
|
Public |
|---|---|
| Traded as | NYSE: VTR S&P 500 Component |
| Industry | Real estate investment trust |
| Founded | 1998 |
| Headquarters | Chicago |
|
Key people
|
Debra Cafaro, Chairman and CEO |
| Revenue |  US$ 3.076 billion (2014) |
|
Net income
|
US$ 475.8 million (2014) |
| Website | http://www.ventasreit.com |
Ventas, Inc., a real estate investment trust (REIT), invests primarily in real estate serving the United States healthcare industry. The company acquires, develops, leases, disposes and manages healthcare real estate. As of 2014 it is a Fortune 1000 corporation.
The company was founded in 1998 as a spin-off of Vencor, a company founded by Bruce Lunsford, who would later be an unsuccessful Democratic candidate for Governor of Kentucky in 2007 and an unsuccessful nominee for Senator from Kentucky in 2008.
According to Richard Daft and Carol Hymowitz, then-CEO Debra Cafaro anticipated the 2008 financial crisis. Her insistence on building cash reserves before the crisis ensured that the company made it through the crisis successfully.
Ventas acquired the real estate investments of Ardent Health Services in 2015.
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-03 | Future report Set alerts | |
| Q2 2022 | 2022-08-04 | 0.00 | 0.00 |
| Q1 2022 | 2022-05-05 | 0.10 | 0.10 |
| Q4 2021 | 2022-02-17 | -0.10 | -0.10 |
| Q3 2021 | 2021-11-05 | 0.16 | 0.16 |
| Q2 2021 | 2021-08-06 | 0.23 | 0.23 |
| Q1 2021 | 2021-05-07 | -0.15 | -0.15 |
| Q4 2020 | 2021-02-18 | 0.29 | 0.29 |
| Q3 2020 | 2020-11-06 | 0.03 | 0.03 |
| Q2 2020 | 2020-08-07 | -0.43 | -0.43 |
| 2016-07-13 | Initiated Coverage | Argus | Hold | |
| 2016-07-07 | Boost Price Target | Citigroup Inc. | Neutral | $64.00 to $70.00 |
| 2016-07-07 | Reiterated Rating | Barclays PLC | Hold | $64.00 |
| 2016-07-06 | Reiterated Rating | BMO Capital Markets | Market Perform | $69.00 |
| 2016-07-06 | Boost Price Target | Mizuho | Buy | $71.00 to $82.00 |
| 2016-06-01 | Initiated Coverage | Barclays | Equal Weight | $59.00 |
| 2016-06-01 | Initiated Coverage | Barclays PLC | Equal Weight | $59.00 |
| 2016-05-12 | Boost Price Target | Deutsche Bank | Hold | $56.00 to $58.00 |
| 2016-05-12 | Boost Price Target | Deutsche Bank AG | Hold | $56.00 to $58.00 |
| 2016-05-02 | Boost Price Target | Barclays | Equal Weight | $59.00 to $64.00 |
| 2016-04-30 | Reiterated Rating | BMO Capital Markets | Hold | |
| 2016-04-29 | Downgrade | Hilliard Lyons | Buy to Neutral | |
| 2016-04-07 | Boost Price Target | Jefferies Group | Hold | $58.00 |
| 2016-04-05 | Reiterated Rating | Mizuho | Buy | $66.00 to $71.00 |
| 2016-03-24 | Downgrade | Goldman Sachs | Buy to Neutral | $60.00 |
| 2016-03-24 | Downgrade | Goldman Sachs Group Inc. | Buy to Neutral | $60.00 |
| 2016-03-21 | Boost Price Target | Evercore ISI | Hold | $52.00 to $57.00 |
| 2016-03-03 | Upgrade | Piper Jaffray | Neutral to Overweight | |
| 2016-03-03 | Upgrade | Mizuho | Neutral to Buy | $51.00 to $66.00 |
| 2016-03-03 | Upgrade | Piper Jaffray Cos. | Neutral to Overweight | |
| 2016-02-22 | Lower Price Target | Deutsche Bank | Hold | $57.00 to $56.00 |
| 2016-02-17 | Lower Price Target | RBC Capital | Outperform | $70.00 to $62.00 |
| 2016-02-17 | Lower Price Target | Royal Bank Of Canada | Outperform | $70.00 to $62.00 |
| 2016-02-16 | Lower Price Target | Mizuho | Neutral | $54.00 to $51.00 |
| 2016-02-16 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2016-01-14 | Downgrade | BMO Capital Markets | Outperform to Market Perform | $59.00 to $58.00 |
| 2016-01-06 | Initiated Coverage | Barclays | Equal Weight | $59.00 |
| 2016-01-05 | Lower Price Target | Deutsche Bank | Hold | $60.00 to $57.00 |
| 2015-11-16 | Lower Price Target | Evercore ISI | Hold | $59.00 to $56.00 |
| 2015-11-12 | Lower Price Target | BMO Capital Markets | Outperform | $61.00 to $59.00 |
| 2015-11-11 | Upgrade | Hilliard Lyons | Neutral to Buy | |
| 2015-11-11 | Lower Price Target | Mizuho | Neutral | $58.00 to $54.00 |
| 2015-10-26 | Lower Price Target | BMO Capital Markets | Outperform | $61.00 |
| 2015-10-26 | Lower Price Target | Deutsche Bank | Hold | $64.00 to $60.00 |
| 2015-10-26 | Downgrade | Evercore ISI | Buy to Hold | $61.00 to $59.00 |
| 2015-10-26 | Downgrade | Mizuho | Buy to Neutral | $58.00 |
| 2015-09-21 | Boost Price Target | Mizuho | Buy | $64.00 to $65.00 |
| 2015-09-14 | Lower Price Target | KeyBanc | $58.00 to $45.00 | |
| 2015-09-14 | Lower Price Target | KeyCorp | $58.00 to $45.00 | |
| 2015-09-08 | Lower Price Target | Evercore ISI | Buy | $65.00 to $61.00 |
| 2015-09-08 | Lower Price Target | Evercore Partners Inc. | Buy | $65.00 to $61.00 |
| 2015-09-04 | Lower Price Target | Mizuho | Buy | $85.00 to $64.00 |
| 2015-09-03 | Reiterated Rating | Deutsche Bank | Hold | $72.00 to $64.00 |
| 2015-08-19 | Boost Price Target | Citigroup Inc. | Neutral | $62.17 to $63.00 |
| 2015-08-19 | Lower Price Target | BMO Capital Markets | Outperform | $74.00 to $65.00 |
| 2015-08-17 | Lower Price Target | Evercore ISI | Buy | $77.00 to $65.00 |
| 2015-08-04 | Reiterated Rating | Deutsche Bank | Hold | $72.00 |
| 2015-07-27 | Upgrade | BMO Capital Markets | Market Perform to Outperform | $74.00 |
| 2015-06-22 | Lower Price Target | Citigroup Inc. | Neutral | $83.00 to $71.00 |
| 2015-06-09 | Reiterated Rating | Evercore ISI | Buy | $81.00 to $77.00 |
| 2015-06-08 | Lower Price Target | Jefferies Group | Hold | $80.00 to $69.00 |
| 2015-05-28 | Reiterated Rating | Mizuho | Buy | $85.00 |
| 2015-05-26 | Reiterated Rating | Deutsche Bank | Hold | $71.00 to $72.00 |
| 2015-04-27 | Lower Price Target | BMO Capital Markets | Market Perform | $79.00 to $77.00 |
| 2015-04-08 | Initiated Coverage | BMO Capital Markets | Market Perform | $79.00 |
| 2015-03-18 | Lower Price Target | Stifel Nicolaus | Buy | $88.00 to $80.00 |
| 2015-02-19 | Boost Price Target | RBC Capital | Outperform | $83.00 |
| 2015-02-17 | Boost Price Target | Barclays | Equal Weight | $77.00 to $81.00 |
| 2015-02-17 | Boost Price Target | Mizuho | Buy | $76.00 to $85.00 |
| 2015-01-26 | Boost Price Target | Deutsche Bank | Hold | $67.00 to $73.00 |
| 2015-01-26 | Reiterated Rating | Citigroup Inc. | Hold | $56.85 to $83.00 |
| 2015-01-08 | Boost Price Target | Barclays | Equal Weight | $68.00 to $77.00 |
| 2015-01-05 | Downgrade | RBC Capital | Top Pick to Outperform | $80.00 |
| 2014-12-11 | Reiterated Rating | Deutsche Bank | Hold | $61.00 to $67.00 |
| 2014-10-10 | Upgrade | Stifel | Hold to Buy | $70 |
| 2014-10-10 | Upgrade | Stifel Nicolaus | Hold to Buy | $70.00 |
| 2014-10-06 | Initiated Coverage | Evercore ISI | Buy | $70.00 |
| 2014-08-18 | Reiterated Rating | Deutsche Bank | Hold | $60.00 to $61.00 |
| 2014-07-23 | Initiated Coverage | Mizuho | Buy | |
| 2014-07-22 | Boost Price Target | Jefferies Group | $67.00 to $71.00 | |
| 2014-06-02 | Boost Price Target | Jefferies Group | $65.00 to $67.00 | |
| 2014-04-28 | Boost Price Target | Barclays | Equal Weight | $62.00 to $65.00 |
| 2014-03-11 | Boost Price Target | Jefferies Group | $65.00 | |
| 2014-01-15 | Reiterated Rating | Deutsche Bank | Hold | $64.00 to $58.00 |
| 2014-01-14 | Upgrade | RBC Capital | Outperform | |
| 2014-01-08 | Lower Price Target | Barclays | Equal Weight | $75.00 to $62.00 |
| 2014-01-06 | Upgrade | RBC Capital | Outperform to Top Pick | $80.00 |
| 2014-01-02 | Downgrade | BMO Capital Markets | Market Perform to Underperform | |
| 2013-10-28 | Lower Price Target | RBC Capital | Outperform | $85.00 to $80.00 |
| 2013-10-28 | Boost Price Target | Jefferies Group | Hold | $63.00 to $67.00 |
| 2013-10-14 | Reiterated Rating | Jefferies Group | Hold | $65.00 to $63.00 |
| 2013-09-18 | Lower Price Target | Jefferies Group | Hold | $71.00 to $65.00 |
| 2012-02-27 | Downgrade | UBS | Buy to Neutral | $60 to $57 |
| 2016-07-13 | Initiated Coverage | Argus | Hold | |
| 2016-07-07 | Boost Price Target | Citigroup Inc. | Neutral | $64.00 to $70.00 |
| 2016-07-07 | Reiterated Rating | Barclays PLC | Hold | $64.00 |
| 2016-07-06 | Reiterated Rating | BMO Capital Markets | Market Perform | $69.00 |
| 2016-07-06 | Boost Price Target | Mizuho | Buy | $71.00 to $82.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In VTR 452 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 65.33M |
| BlackRock Inc. | 42.18M |
| STATE STREET CORP | 28.92M |
| JPMORGAN CHASE & CO | 25.60M |
| FMR LLC | 19.51M |
| APG Asset Management US Inc. | 19.05M |
| PRINCIPAL FINANCIAL GROUP INC | 17.52M |
| BlackRock Institutional Trust Company, N.A. | 15.02M |
| BlackRock Fund Advisors | 11.77M |
| GEODE CAPITAL MANAGEMENT, LLC | 8.80M |
| COHEN & STEERS CAPITAL MANAGEMENT INC | 6.93M |
| NORTHERN TRUST CORP | 5.70M |
| DIMENSIONAL FUND ADVISORS LP | 5.57M |
| MANAGED ACCOUNT ADVISORS LLC | 5.35M |
| LEGAL & GENERAL GROUP PLC | 5.34M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| CAFARO DEBRA A Chairman and CEO | 0.25% (744167) | GGP / PNC / VTR / WY / |
| LEWIS RAYMOND J President | 0.06% (190211) | CCP / SBRA / VTR / |
| RINEY T RICHARD EVP, Chief Admin. Off., GC | 0.06% (178125) | VTR / |
| SCHWEINHART RICHARD A EVP & CFO | 0.05% (140628) | VTR / |
| GELLERT JAY M | 0.05% (132680) | HNT / VTR / |
| Lillibridge Todd W. EVP, Medical Prop. Operations | 0.04% (131833) | VTR / |
| CROCKER DOUGLAS II | 0.04% (104427) | AEC / AKR / CCP / CYS / VTR / |
| PASQUALE DOUGLAS M | 0.04% (104022) | ALEX / DIN / MATX / SHO / TRNO / VTR / |
| Cobb John D. EVP, Chief Investment Off. | 0.03% (96340) | VTR / |
| Probst Robert F EVP, CFO and Acting CAO | 0.03% (94702) | BEAM / VTR / |
| ROSENBERG SHELI Z | 0.03% (84978) | BEE / ELS / GGP / ICEL / NSPH / SRC / VTR / |
| RUFRANO GLENN J | 0.01% (34814) | ARCP / CXP / GGP / VTR / |
| Reed Robert D. | 0.01% (31498) | VTR / |
| SHELTON JAMES D | 0.01% (30233) | EVHC / OCR / VTR / |
| LUSTIG MATTHEW J | 0.01% (28886) | BXP / VTR / |
| GILCHRIST RICHARD I | 0.01% (23932) | BMR / SRC / VTR / |
| Brehl Robert J Chief Acct. Off. & Controller | 0.01% (21431) | VTR / |
| GEARY RONALD G | 0.01% (20262) | CCP / SBRA / VTR / |
UM